---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-025709"
form_type: "8-K"
ticker: "INSM"
cik: "0001104506"
company_name: "INSMED Inc"
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T01:54:02.532574+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Insmed shareholders elect four Class III directors and approve 2019 Incentive Plan amendment

## Summary
- Elected David R. Brennan, Leo Lee, Carol A. Schafer, Melvin Sharoky as Class III directors until 2027.
- Advisory vote on 2023 executive compensation passed: 120.6M for, 8.1M against, 96.8K abstentions.
- Ratified Ernst & Young as independent auditor for 2024: 135.5M for, 4.2M against, 61.8K abstentions.
- Approved Amendment No. 1 to the 2019 Incentive Plan: 122.2M for, 6.6M against, 56.8K abstentions.

## SEC filing metadata
- accession: 0001140361-24-025709
- form_type: 8-K
- ticker: INSM
- cik: 0001104506
- company_name: INSMED Inc
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/ef20029006_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-025709
- JSON: https://secwatch.observer/filing/0001140361-24-025709.json
- Plain text: https://secwatch.observer/filing/0001140361-24-025709.txt

## Key facts
- Shareholder Votes
  INSMED Inc shareholders approved Ratification of the Appointment of an Independent Registered Public Accounting Firm at the 2024-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-12-31
  source text: Proposal 3. Ratification of the Appointment of an Independent Registered Public Accounting Firm. By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024: For Against Abstentions 135,507,026 4,170,279 61,773
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm
- Shareholder Votes
  INSMED Inc shareholders approved Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: Proposal 4. Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan. By the following vote, shareholders approved Amendment No. 1 to the 2019 Incentive Plan: For Against Abstentions Broker Non-Votes 122,169,823 6,589,414 56,760 10,923,081
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm
- Shareholder Votes
  INSMED Inc shareholders approved Election of Four Class III Directors.
  - Proposal: director election
  - Outcome: passed
  source text: Proposal 1. Election of Four Class III Directors. By the following votes, shareholders elected David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D. to serve as Class III directors until the Company’s 2027 Annual Meeting of Shareholders: For Withheld Broker Non-Votes David R. Brennan 120,537,761 8,278,236 10,923,081 Leo Lee 125,634,442 3,181,555 10,923,081 Carol A. Schafer 113,910,394 14,905,603 10,923,081 Melvin Sharoky, M.D. 117,140,717 11,675,280 10,923,081
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm
- Shareholder Votes
  INSMED Inc shareholders approved Advisory Vote on the 2023 Compensation of Named Executive Officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: Proposal 2. Advisory Vote on the 2023 Compensation of Named Executive Officers. By the following vote, shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in the Proxy Statement: For Against Abstentions Broker Non-Votes 120,643,045 8,076,144 96,808 10,923,081
  evidence_url: https://www.sec.gov/Archives/edgar/data/1104506/000114036124025709/0001140361-24-025709-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.